Directory

>

Ann Gelormini

avatar

Ann Gelormini

Vice President, Pharmaceutical Development & Manufacturing | Deciphera Pharmaceuticals

Waltham, Massachusetts, United States

View contact details (it's free)

Ann Gelormini

Summary

Ann Gelormini is a seasoned CMC professional with extensive experience in pharmaceutical development and manufacturing, currently serving as Vice President at Deciphera Pharmaceuticals. With a strong background in both big pharma and biotech, she has successfully managed cross-functional teams and multiple projects across various stages of drug development. Ann's expertise lies in CMC activities, from preclinical through to commercialization, making her a key player in the industry. She is known for her ability to navigate complex regulatory environments and her strong technical skills in organic chemistry and analytical sciences. Her leadership has been instrumental in advancing several clinical candidates, including ripretinib. Ann holds a Ph.D. in Chemistry from Case Western Reserve University and has completed post-doctoral research at Harvard University. Her commitment to innovation and collaboration continues to drive her career forward.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Ann Gelormini

Work Experience

company logo

Vice President, Pharmaceutical Development & Manufacturing at

Deciphera Pharmaceuticals

April 2024 - Present

company logo

Vice President, Chemical Development & Manufacturing at

Deciphera Pharmaceuticals

January 2022 - April 2024

company logo

Sr. Director, Manufacturing Sciences & Technology at

Deciphera Pharmaceuticals

March 2019 - December 2021

company logo

Director, Chemistry, Manufacturing, and Controls at

Ocular Therapeutix, Inc.

January 2017 - March 2019

company logo

Director, Chemistry, Manufacturing, and Controls at

Entasis Therapeutics

January 2015 - January 2017

💼

Director, Drug Process Development at

AEGERION PHARMACEUTICALS LIMITED

January 2012 - January 2015

💼

Manager, Chemical Process Development at

Aegerion Pharma

January 2012 - January 2012

💼

Manager, Chemical Development at

Dogwood Pharmaceuticals A Subsidiary Of Forest Labs

January 2010 - January 2012

company logo

Principal Research Investigator at

Sanofi

January 2002 - January 2010

company logo

Sr. Scientist at

Johnson & Johnson

January 1999 - January 2002

Logos provided by Logo.dev

Ann Gelormini

Education

Amridge University

January 1996

Harvard University, Post-Doc

January 1997 - January 1999

Case Western Reserve University, Ph.D.

January 1991 - January 1996

Case Western Reserve University, Bachelor Of Science In Chemistry

January 1987 - January 1991

Frequently Asked Questions about Ann Gelormini

What is Ann Gelormini email address?

Ann Gelormini's primary email address is **********@deciphera.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Ann Gelormini work for?

Ann Gelormini is a Vice President, Pharmaceutical Development & Manufacturing at Deciphera Pharmaceuticals, a company specializing in Pharmaceutical & Medicine Manufacturing.

Where Ann Gelormini graduated from?

Ann Gelormini holds a degree in Exchange Visiting Post Doctoral Fellow With Prof. Ian Fleming from Amridge University.

How can I directly contact Ann Gelormini?

To contact Ann Gelormini directly, you can use the email address **********@deciphera.com. Complete contact information is available upon registration with Muraena.

Who is Ann Gelormini?

Ann Gelormini is a seasoned CMC professional with extensive experience in pharmaceutical development and manufacturing, currently serving as Vice President at Deciphera Pharmaceuticals. With a strong background in both big pharma and biotech, she has successfully managed cross-functional teams and multiple projects across various stages of drug development. Ann's expertise lies in CMC activities, from preclinical through to commercialization, making her a key player in the industry. She is known for her ability to navigate complex regulatory environments and her strong technical skills in organic chemistry and analytical sciences. Her leadership has been instrumental in advancing several clinical candidates, including ripretinib. Ann holds a Ph.D. in Chemistry from Case Western Reserve University and has completed post-doctoral research at Harvard University. Her commitment to innovation and collaboration continues to drive her career forward.

Ann`s contact details

mail

**********@deciphera.com

***********@att.net

Colleagues

avatar
Paloma Iturralde

VP, Head of Commercial International & Iberia GM

avatar
Peter Habura

VP, Quality Assurance

avatar
Amit Verma

Vice President

Tao Wang

Vice President, Head of Biometrics

avatar
Michelle Dinapoli

Senior Vice President, US Commercial

avatar
Michael Kaufman

VP of Chemistry and Preclinical Development

avatar
Saran Chhabra

Executive Director and Head of Global Medical Writing & Clinical Trial Disclosure

avatar
Stacey Limauro

Executive Director, Clinical Operations

avatar
Priya Jain

VP, Head of Pharmacovigilance

avatar
Bianca Buechner

General Manager DACH

View Contact details (it's free)
Request Profile Removal